IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Brain and Central Nervous System Tumors
University of Illinois at Chicagomonoclonal_antibodyPhase 2Dormant
BB
71/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 56/ 100
- Competitive Position
- 95/ 100
Competitive context
48 Active assets in the Brain and Central Nervous System Tumors cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Procarbazine Universitätsmedizin Mannheim | Phase 3 | BBB |
VINCRISTINE SULFATE Northwestern University | Phase 3 | BBB |
Irinotecan EpicentRx, Inc. | Phase 2 | BBB |
Gefetinib Memorial Sloan Kettering Cancer Center | Phase 2 | BBB |
ETOPOSIDE NewLink Genetics Corporation | Phase 3 | BBB |
View all 50 →
Same molecule, other indications
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →